Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Obviously TPL can't take every target to court, we don't have the time or money.
We are having another Markman because the patents were reexamined and new patents are at issue. The 749 and 890 are new patents in the MMP be asserted against companies. The 336 was reexamined.
Share
New Message
Please login to post a reply